New Paper- Mitigating Oxidative Stress and Anti-Angiogenic State in an In Vitro Model of Preeclampsia by HY-12, an Organofluorine Hydrazone Antioxidant
A new paper has been published with Dr. Zsengeller as first author. The abstract and links are below: https://pubmed.ncbi.nlm.nih.gov/41020802/ Preeclampsia (PE) is a hypertensive disorder impacting 5-7% of pregnancies globally. With no causative treatment available, diagnosed patients have limited...